Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06492265

Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-B )

Emergency Stroke Unit for Acute Cerebrovascular Events--A Prospective, Multicenter, Week-wise Randomized, Controlled Trial ( ESU-ACE-B )

Status
Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Yongjun Wang · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To compare the door-to-puncture time of patients with hyperacute ischemic stroke (between 4.5-6 hours after the onset of symptoms) treated in a standard stroke unit adherent to guidelines versus treated in Emergency Stroke Unit (a new stroke unit based on low-field magnetic resonance imaging).

Detailed description

Mechanical thrombectomy is an effective reperfusion therapy for patients with acute ischemic stroke due to large vessel occlusion. Faster door-to-puncture time (DPT) is associated with significantly better clinical outcomes. With the development of low-field magnetic resonance imaging, it is poised to play an increasingly significant role in the early diagnosis and management of acute ischemic stroke. This prospective, multicenter, week-wise randomized controlled trial will compare the door-to-puncture time of patients with hyperacute ischemic stroke (between 4.5-6 hours after the onset of symptoms) managed in a standard stroke unit adherent to guidelines versus managed in Emergency Stroke Unit (a new stroke unit based on low-field magnetic resonance imaging).

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTEmergency Stroke Unit based on 0.23-T MRIThe participants with hyperacute ischemic stroke (between 4.5-6 hours after onset of symptoms) who are eligible to receive reperfusion therapy will be managed by Emergency Stroke Unit process based on low-field magnetic resonance imaging.
COMBINATION_PRODUCTStandard stroke unit adherent to guidelinesThe participants with hyperacute ischemic stroke (between 4.5-6 hours after onset of symptoms) who are eligible to receive reperfusion therapy will be managed by standard stroke unit process adherent to guidelines.

Timeline

Start date
2024-08-04
Primary completion
2025-02-01
Completion
2025-04-01
First posted
2024-07-09
Last updated
2024-08-12

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06492265. Inclusion in this directory is not an endorsement.